Belpointe Asset Management LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 198 filers reported holding HERON THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 2.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
Belpointe Asset Management LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$260
-99.8%
104
-98.7%
0.00%
-100.0%
Q4 2020$166,000
-54.8%
7,871
-71.4%
0.02%
-40.0%
Q3 2020$367,000
+74.8%
27,500
+92.3%
0.02%
-7.4%
Q2 2020$210,000
+35.5%
14,300
+8.3%
0.03%0.0%
Q1 2020$155,000
-58.2%
13,200
-16.5%
0.03%
-42.6%
Q4 2019$371,000
+27.1%
15,8000.0%0.05%0.0%
Q3 2019$292,000
+17.3%
15,800
+18.0%
0.05%
-4.1%
Q2 2019$249,000
-22.9%
13,393
+1.5%
0.05%
-22.2%
Q1 2019$323,00013,2000.06%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
TANG KEVIN C 21,288$250,00019.87%
TANG CAPITAL MANAGEMENT LLC 2,896,904$34,010,0004.78%
PFM Health Sciences, LP 2,481,917$29,138,0002.39%
Iron Triangle Partners LP 500,000$5,870,0002.27%
NEXPOINT ASSET MANAGEMENT, L.P. 777,599$9,129,0001.72%
Pekin Hardy Strauss, Inc. 588,732$6,912,0001.55%
First Light Asset Management, LLC 691,400$8,117,0001.39%
Congress Park Capital LLC 111,045$1,304,0001.18%
Mesirow Financial Investment Management, Inc. 15,135$178,0001.12%
Elk Creek Partners, LLC 509,174$5,978,0001.03%
View complete list of HERON THERAPEUTICS INC shareholders